Bioceltix
Blood & Organ Banks · Poland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ul. Eugeniusza Kwiatkowskiego 4, Wroclaw...Phone Number
+48 718808771Website
www.bioceltix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Bioceltix
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bioceltix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bioceltix is spiking on competitors!
Earning: See what the market has to say on Bioceltix recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Bioceltix
Funding: Get notified immidiatlly once Bioceltix has new funding data
Product Launch: Get notified when Bioceltix launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bioceltix has recently received funding, and reach out quickly before it becomes old news!
Bioceltix, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Bioceltix had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Bioceltix as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Bioceltix is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Bioceltix is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Bioceltix.
Bioceltix Tech Stack
A closer look at the technologies used by Bioceltix
Top Blood & Organ Banks Companies
Frequently Asked Questions Regarding Bioceltix
Bioceltix SA is a Polish biotechnology company specializing in veterinary biological drugs, listed on the Warsaw Stock Exchange. The company develops innovative therapeutic products for companion animals, utilizing the immunomodulatory properties of mesenchymal stem cells to address inflammatory and autoimmune diseases. Their product line includes... Read More
